ReP USP - Resultado da busca

Filtros : "FÁRMACOS" "Financiamento Conicet, Argentina" Removidos: "HERNANDES, ANTONIO CARLOS" "ROCHA, PAULO ARCHIAS MENDES DA" "Espanha" Limpar

Filtros

Artigo de periodico
Crystalline and amorphous famotidine malate as pathways to prevent polymorphic transformation with improved dissolution (2023)
Russo, Marcos Guillermo ; Brusau, Elena Virginia; Ellena, Javier ; Narda, Griselda Edith
Fonte: International Journal of Pharmaceutics. Unidade: IFSC
Assuntos: ANTI-HISTAMÍNICOS H2, CRISTALOGRAFIA, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUSSO, Marcos Guillermo et al. Crystalline and amorphous famotidine malate as pathways to prevent polymorphic transformation with improved dissolution. International Journal of Pharmaceutics, v. 642, p. 123053-1-123053-10 + supplementary material, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2023.123053. Acesso em: 02 nov. 2024.
APA
Russo, M. G., Brusau, E. V., Ellena, J., & Narda, G. E. (2023). Crystalline and amorphous famotidine malate as pathways to prevent polymorphic transformation with improved dissolution. International Journal of Pharmaceutics, 642, 123053-1-123053-10 + supplementary material. doi:10.1016/j.ijpharm.2023.123053
NLM
Russo MG, Brusau EV, Ellena J, Narda GE. Crystalline and amorphous famotidine malate as pathways to prevent polymorphic transformation with improved dissolution [Internet]. International Journal of Pharmaceutics. 2023 ; 642 123053-1-123053-10 + supplementary material.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.ijpharm.2023.123053
Vancouver
Russo MG, Brusau EV, Ellena J, Narda GE. Crystalline and amorphous famotidine malate as pathways to prevent polymorphic transformation with improved dissolution [Internet]. International Journal of Pharmaceutics. 2023 ; 642 123053-1-123053-10 + supplementary material.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.ijpharm.2023.123053
Artigo de periodico
Water-mediated reduction of [Cu(dmp)2(CH3CN)]2+: implications of the structure of a classical complex on its activity as an anticancer drug (2021)
Levín, Pedro ; Ruiz, María C.; Romo, Adolfo I. B.; Nascimento, Otaciro Rangel ; Virgilio, Ana L. Di; Oliver, Allen G.; Ayala, Alejandro Pedro ; Diógenes, Izaura C. N. ; León, Ignacio E. ; Lemus, Luis
Fonte: Inorganic Chemistry Frontiers. Unidade: IFSC
Assuntos: ANTINEOPLÁSICOS, NEOPLASIAS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEVÍN, Pedro et al. Water-mediated reduction of [Cu(dmp)2(CH3CN)]2+: implications of the structure of a classical complex on its activity as an anticancer drug. Inorganic Chemistry Frontiers, v. 8, n. 13, p. 3238-3252, 2021Tradução . . Disponível em: https://doi.org/10.1039/d1qi00233c. Acesso em: 02 nov. 2024.
APA
Levín, P., Ruiz, M. C., Romo, A. I. B., Nascimento, O. R., Virgilio, A. L. D., Oliver, A. G., et al. (2021). Water-mediated reduction of [Cu(dmp)2(CH3CN)]2+: implications of the structure of a classical complex on its activity as an anticancer drug. Inorganic Chemistry Frontiers, 8( 13), 3238-3252. doi:10.1039/d1qi00233c
NLM
Levín P, Ruiz MC, Romo AIB, Nascimento OR, Virgilio ALD, Oliver AG, Ayala AP, Diógenes ICN, León IE, Lemus L. Water-mediated reduction of [Cu(dmp)2(CH3CN)]2+: implications of the structure of a classical complex on its activity as an anticancer drug [Internet]. Inorganic Chemistry Frontiers. 2021 ; 8( 13): 3238-3252.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1039/d1qi00233c
Vancouver
Levín P, Ruiz MC, Romo AIB, Nascimento OR, Virgilio ALD, Oliver AG, Ayala AP, Diógenes ICN, León IE, Lemus L. Water-mediated reduction of [Cu(dmp)2(CH3CN)]2+: implications of the structure of a classical complex on its activity as an anticancer drug [Internet]. Inorganic Chemistry Frontiers. 2021 ; 8( 13): 3238-3252.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1039/d1qi00233c

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo 2012 - 2024